Skip to main content

Revance Therapeutics Inc (NASDAQ: RVNC) Investor Securities Class Action Lawsuit 06/10/2015

  • You must submit the settlement "Proof" form attached below, in order to participate in this settlement. There is a strict deadline of June 5, 2017 by which all claims must be submitted. The instructions for submitting are included in the "Proof" and the "Notice" files attached below for your download. DO NOT SEND THE FORMS TO THE SHAREHOLDERS FOUNDATION, INC.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

August 1, 2017 - The court granted final approval of the settlement. January 6, 2017 - The court preliminarily approved the settlement. October 31, 2016 - A stipulation of settlement was filed by the parties. June 10, 2015 - An investor in shares of Revance Therapeutics Inc (NASDAQ: RVNC) filed a lawsuit over alleged violations of Federal Securities Laws by Revance Therapeutics Inc re...



You must register (for free) or login to view the entire case.